Bank Julius Baer & Co. Ltd Zurich Has $257.63 Million Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bank Julius Baer & Co. Ltd Zurich lessened its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.7% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 763,659 shares of the medical equipment provider’s stock after selling 13,248 shares during the quarter. Intuitive Surgical makes up approximately 1.4% of Bank Julius Baer & Co. Ltd Zurich’s investment portfolio, making the stock its 19th largest holding. Bank Julius Baer & Co. Ltd Zurich’s holdings in Intuitive Surgical were worth $257,628,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Vanguard Group Inc. boosted its holdings in shares of Intuitive Surgical by 0.7% during the 3rd quarter. Vanguard Group Inc. now owns 29,868,227 shares of the medical equipment provider’s stock worth $8,730,184,000 after buying an additional 196,316 shares in the last quarter. Jennison Associates LLC boosted its holdings in shares of Intuitive Surgical by 6.4% during the 3rd quarter. Jennison Associates LLC now owns 4,585,190 shares of the medical equipment provider’s stock worth $1,340,205,000 after buying an additional 274,692 shares in the last quarter. Invesco Ltd. boosted its holdings in shares of Intuitive Surgical by 6.6% during the 3rd quarter. Invesco Ltd. now owns 3,750,490 shares of the medical equipment provider’s stock worth $1,096,231,000 after buying an additional 232,205 shares in the last quarter. Northern Trust Corp boosted its holdings in shares of Intuitive Surgical by 3.4% during the 3rd quarter. Northern Trust Corp now owns 3,514,421 shares of the medical equipment provider’s stock worth $1,027,230,000 after buying an additional 115,059 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in shares of Intuitive Surgical by 0.9% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 2,030,415 shares of the medical equipment provider’s stock worth $593,470,000 after buying an additional 17,477 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Ratings Changes

ISRG has been the topic of a number of recent research reports. Wells Fargo & Company increased their target price on Intuitive Surgical from $363.00 to $416.00 and gave the stock an “overweight” rating in a report on Friday, January 19th. Barclays increased their target price on Intuitive Surgical from $385.00 to $430.00 and gave the stock an “overweight” rating in a report on Thursday, January 25th. Jefferies Financial Group increased their target price on Intuitive Surgical from $365.00 to $375.00 and gave the stock a “hold” rating in a report on Friday, April 19th. BTIG Research increased their target price on Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a report on Friday, April 19th. Finally, Robert W. Baird cut their target price on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a report on Friday, April 19th. Five analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average target price of $396.17.

Intuitive Surgical Stock Down 0.5 %

NASDAQ ISRG traded down $1.89 on Thursday, reaching $373.12. The company had a trading volume of 1,262,491 shares, compared to its average volume of 1,667,548. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $403.76. The stock has a market capitalization of $132.35 billion, a P/E ratio of 67.58, a P/E/G ratio of 4.83 and a beta of 1.36. The company’s fifty day moving average is $386.40 and its 200 day moving average is $345.19.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The firm had revenue of $1.89 billion during the quarter, compared to analyst estimates of $1.87 billion. During the same period last year, the firm posted $1.00 EPS. The business’s revenue was up 11.5% compared to the same quarter last year. On average, research analysts expect that Intuitive Surgical, Inc. will post 4.84 EPS for the current year.

Insider Activity

In related news, EVP Myriam Curet sold 4,318 shares of Intuitive Surgical stock in a transaction dated Friday, January 26th. The stock was sold at an average price of $370.15, for a total value of $1,598,307.70. Following the completion of the sale, the executive vice president now owns 189 shares of the company’s stock, valued at approximately $69,958.35. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other Intuitive Surgical news, Director Alan J. Levy sold 2,000 shares of the firm’s stock in a transaction dated Friday, January 26th. The stock was sold at an average price of $370.20, for a total value of $740,400.00. Following the completion of the transaction, the director now owns 25,319 shares in the company, valued at approximately $9,373,093.80. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Myriam Curet sold 4,318 shares of the firm’s stock in a transaction dated Friday, January 26th. The stock was sold at an average price of $370.15, for a total value of $1,598,307.70. Following the completion of the transaction, the executive vice president now owns 189 shares of the company’s stock, valued at approximately $69,958.35. The disclosure for this sale can be found here. Insiders sold a total of 255,736 shares of company stock valued at $98,639,667 in the last ninety days. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.